Delivery Order SPE2DB25D3402-SPE2DB25FUFXA
Award Date
1/28/25
Potential Completion Date
2/19/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.50 delivery order contract is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of March 17, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,513.75, is a Delivery Order with a Firm Fixed Price pricing type. It covers the provision of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty pharmaceutical product, to support military healthcare programs. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award, with an ID of SPE2DB20D1100 and SPE2DB25FA7A1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $6,674.00 firm fixed-price delivery order is for the pharmaceutical product XOLAIR 150 MG/1.2 ML POWDER VLS, with a period of performance through March 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of XOLAIR 150 mg/mL autoinjectors, with a ceiling value of $8,475.96 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $4,622.70 for the supply of XOLAIR 150 MG/ML autoinjector medication. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a firm fixed price pricing structure with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company. The $38,522.50 firm-fixed-price contract is for the supply of XOLAIR 150 MG/ML autoinjectors, with a completion date of May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of XOLAIR 75 MG/0.5 ML AUTOINJECT 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,405.36, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded on September 15, 2022 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $39,584.16 and an ultimate completion date of October 6, 2022. DMS Pharmaceutical Group Inc. holds a larger...
This federal contract award is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order structure and a total ceiling value of $92,844.00. It is not designated as a set-aside award. The contract is part of a larger indefinite delivery contract (IDC) with DLA...
This federal contract award, valued at $6,189.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 7, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...